Ophthalmic Devices Market by Product Function [Surgical Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices) Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometer), and Vision Care Devices (Contact Lenses and Spectacles)]: Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4162621
- 205 Pages
- November 2020
- Pharmaceuticals
Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. They cover a wide range of design types and applications such as contact lenses, glasses, intraocular lenses, implants, lasers, diagnostics, and surgical instruments. These devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.
The growth of the global ophthalmic devices market is majorly driven by rise In incidence of vision disorders, technological advancements in ophthalmic devices such as intraocular lenses (IOLs), and increase in focus on customer training & education for use of ophthalmic devices, which would help in building the staff skills. In addition, increase in R&D developments for novel devices development related to vision error and surge in awareness related to devices used in ophthalmology contribute toward the growth of the global market. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. On the contrary, emerging countries such as China and India possess high growth potential, owing to improvement in healthcare infrastructure in these countries, which is anticipated to offer remunerative opportunities for the expansion of the market during the forecast period.
Depending on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices.
The ophthalmic diagnostic devices segment is subsegmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer.
The vision care devices segment is bifurcated into contact lenses and spectacle lenses
On a regional level, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share; however, Asia-Pacific is anticipated to grow with the highest CAGR of 4.6% during the forecast period.
The global ophthalmology devices market is highly competitive in nature, as major players have focused on the development and launch of innovative products to garner maximum share in the competitive market. The key players operating in the market include Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, HOYA Corporation, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry include Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global ophthalmic devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ophthalmic devices market growth.
KEY MARKET SEGMENTS
By Product Function
• Ophthalmic Surgical Devices
o Refractive Error Surgical Devices
o Glaucoma Surgical Devices
o Cataract Surgery Devices
o Vitreoretinal Surgical Devices
• Ophthalmic Diagnostic Devices
o Refractors
o Corneal Topography Systems
o Retinal Ultrasound Systems
o Fundus Camera
o Ophthalmoscopes
o Optical Coherence Tomography Systems
o Perimeters
o Slit Lamps
o Tonometer’s
• Ophthalmic Vision Care Devices
o Contact Lenses
o Spectacle Lenses
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA
List of key players profiled in the report
• Novartis AG
• Carl Zeiss Meditec AG
• Essilor International S.A.
• HAAG-Streit Holding AG
• Johnson & Johnson
• Nidek Co., Ltd.
• Topcon Corporation
• Valeant Pharmaceuticals International, Inc.
• Ziemer Ophthalmic Systems AG
• Hoya Corporation
List of other players in the value chain (profiles not included in the report):
• Sonomed Escalon
• Gulden Ophthalmics
• FCI Ophthalmics
• Glaukos Corporation
• STAAR Surgical GE Healthcare
1.1.Report description
1.1.1.Key benefits for stakeholders
1.1.2.Key market segments
1.2.Research methodology
1.2.1.Secondary research
1.2.2.Primary research
1.2.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top winning strategies
3.2.2.Top player positioning, 2019
3.2.3.Key forces shaping the global ophthalmic devices market
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in prevalence of eye-related diseases worldwide
3.3.1.2.Rapid technological advancements in ophthalmic
3.3.1.3.Increase in focus on customer training and education along with awareness
3.3.1.4.High adoption of digital devices worldwide
3.3.2.Restraints
3.3.2.1.Low awareness about eye-related diseases
3.3.2.2.Dearth of skilled professionals
3.3.3.Opportunities
3.3.3.1.Potential growth opportunities in emerging nations for ophthalmic devices manufacturers
3.4.Government regulations
3.4.1.FDA
3.4.2.CE Mark
3.4.3.Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)
3.5.Impact of COVID-19 on ophthalmic devices market
CHAPTER 4:OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION
4.1.Overview
4.1.1.Market size and forecast, by region
4.2.Surgical devices
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Refractive error surgical devices
4.2.3.1.Market size and forecast
4.2.3.2.Market size and forecast, by type
4.2.3.3.Excimers and femtosecond lasers
4.2.3.4.Market size and forecast
4.2.3.5.Microkeratomes
4.2.3.6.Market size and forecast
4.2.4.Glaucoma surgical devices
4.2.4.1.Market size and forecast
4.2.4.2.Market size and forecast, by type
4.2.4.3.Implants and stents
4.2.4.4.Market size and forecast
4.2.4.5.Glaucoma drainage devices
4.2.4.6.Market size and forecast
4.2.4.7.Glaucoma laser devices
4.2.4.8.Market size and forecast
4.2.5.Cataract surgical devices
4.2.5.1.Market size and forecast
4.2.5.2.Market size and forecast, by type
4.2.5.3.Intraocular lenses
4.2.5.4.Market size and forecast
4.2.5.5.Viscoelastic
4.2.5.6.Market size and forecast
4.2.5.7.Phacoemulsification systems
4.2.5.8.Market size and forecast
4.2.6.Vitreoretinal surgical devices
4.2.6.1.Market size and forecast
4.2.6.2.Market size and forecast, by type
4.2.6.3.Vitrectomy machines and vitrectomy packs
4.2.6.4.Market size and forecast
4.2.6.5.Photocoagulation lasers
4.2.6.6.Market size and forecast
4.2.6.7.Illumination devices
4.2.6.8.Market size and forecast
4.3.Diagnostic devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Refractors
4.3.3.1.Market size and forecast
4.3.4.Corneal topography systems
4.3.4.1.Market size and forecast
4.3.5.Retinal ultrasound systems
4.3.5.1.Market size and forecast
4.3.6.Fundus camera
4.3.6.1.Market size and forecast
4.3.7.Ophthalmoscopes
4.3.7.1.Market size and forecast
4.3.8.Optical coherence tomography systems
4.3.8.1.Market size and forecast
4.3.9.Perimeters
4.3.9.1.Market size and forecast
4.3.10.Slit lamps
4.3.10.1.Market size and forecast
4.3.11.Tonometer
4.3.11.1.Market size and forecast
4.4.Vision care devices
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Contact lenses
4.4.3.1.Market size and forecast
4.4.4.Spectacle lenses
4.4.4.1.Market size and forecast
CHAPTER 5:OPHTHALMIC DEVICES MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast
5.2.North America
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by product function
5.2.3.Market size and forecast, by region
5.2.4.U.S.
5.2.4.1.Market size and forecast, by product function
5.2.5.Canada
5.2.5.1.Market size and forecast, by product function
5.2.6.Mexico
5.2.6.1.Market size and forecast, by product function
5.3.Europe
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by product function
5.3.3.Market size and forecast, by region
5.3.4.Germany
5.3.4.1.Market size and forecast, by product function
5.3.5.France
5.3.5.1.Market size and forecast, by product function
5.3.6.UK
5.3.6.1.Market size and forecast, by product function
5.3.7.Italy
5.3.7.1.Market size and forecast, by product function
5.3.8.Spain
5.3.8.1.Market size and forecast, by product function
5.3.9.Rest of the Europe
5.3.9.1.Market size and forecast, by product function
5.4.Asia-Pacific
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by product function
5.4.3.Market size and forecast, by region
5.4.4.Japan
5.4.4.1.Market size and forecast, by product function
5.4.5.China
5.4.5.1.Market size and forecast, by product function
5.4.6.Australia market size and forecast
5.4.6.1.Market size and forecast, by product function
5.4.7.India
5.4.7.1.Market size and forecast, by product function
5.4.8.Rest of Asia-Pacific
5.4.8.1.Market size and forecast, by product function
5.5.LAMEA
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by product function
5.5.3.Market size and forecast, by region
5.5.4.Brazil
5.5.4.1.Market size and forecast, by product function
5.5.5.Saudi Arabia market size and forecast
5.5.5.1.Market size and forecast, by product function
5.5.6.South Africa
5.5.6.1.Market size and forecast, by product function
5.5.7.Rest of LAMEA
5.5.7.1.Market size and forecast, by product function
CHAPTER 6:COMPANY PROFILES
6.1.CARL ZEISS MEDITEC AG
6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.2.ESSILOR INTERNATIONAL S.A.
6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.2.6.Key strategic moves and developments
6.3.HAAG-STREIT HOLDING AG
6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.4.HOYA CORPORATION
6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Business performance
6.4.5.Key strategic moves and developments
6.5.JOHNSON & JOHNSON
6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product portfolio
6.5.5.Business performance
6.5.6.Key strategic moves and developments
6.6.NIDEK CO., LTD.
6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Key strategic moves & developments
6.7.NOVARTIS AG (ALCON-A DIVISION OF NOVARTIS)
6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.7.5.Business performance
6.8.TOPCON CORPORATION
6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Business performance
6.9.BAUSCH HEALTH COMPANIES INC.
6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Business performance
6.10.ZIEMER OPHTHALMIC SYSTEMS AG
6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Product portfolio
6.11.List of mergers and acquisitions (M&A) activities
TABLE 01.GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 02.GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 03.GLOBAL REFRACTIVE ERROR SURGERY DEVICES MARKET, BY TYPE 2019-2027
TABLE 04.GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE 2019-2027
TABLE 05.GLOBAL CATARACT SURGERY DEVICES MARKET, BY TYPE 2019-2027
TABLE 06.GLOBAL VITREORETINAL EYE SURGERY MARKET, BY TYPE 2019-2027
TABLE 07.OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 08.OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.OPHTHALMIC DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 11.NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 12.U.S. OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 13.CANADA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 14.MEXICO OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 15.EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 16.EUROPE OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.GERMANY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 18.FRANCE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 19.UK OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 20.ITALY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 21.SPAIN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 22.REST OF EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 23.ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 24.ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.JAPAN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 26.CHINA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 27.AUSTRALIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 28.INDIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 29.REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 30.LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 31.LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.BRAZIL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 33.SAUDI ARABIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 34.SOUTH AFRICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 35.REST OF LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 36.CARL ZEISS: COMPANY SNAPSHOT
TABLE 37.CARL ZEISS: OPERATING SEGMENTS
TABLE 38.CARL ZEISS: PRODUCT PORTFOLIO
TABLE 39.ESSILOR: COMPANY SNAPSHOT
TABLE 40.ESSILOR: OPERATING SEGMENTS
TABLE 41.ESSILOR: PRODUCT PORTFOLIO
TABLE 42.HAAG-STREIT: COMPANY SNAPSHOT
TABLE 43.HAAG-STREIT: OPERATING SEGMENTS
TABLE 44.HOYA: COMPANY SNAPSHOT
TABLE 45.HOYA: OPERATING SEGMENTS
TABLE 46.J&J: COMPANY SNAPSHOT
TABLE 47.J&J: OPERATING SEGMENTS
TABLE 48.J&J: PRODUCT PORTFOLIO
TABLE 49.NIDEK: COMPANY SNAPSHOT
TABLE 50.NIDEK: OPERATING SEGMENTS
TABLE 51.NOVARTIS: COMPANY SNAPSHOT
TABLE 52.NOVARTIS: OPERATING SEGMENTS
TABLE 53.NOVARTIS: PRODUCT PORTFOLIO
TABLE 54.TOPCON: COMPANY SNAPSHOT
TABLE 55.TOPCON: OPERATING SEGMENTS
TABLE 56.TOPCON: PRODUCT PORTFOLIO
TABLE 57.BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT
TABLE 58.BAUSCH HEALTH COMPANIES : OPERATING SEGMENTS
TABLE 59.BAUSCH HEALTH COMPANIES: PRODUCT PORTFOLIO
TABLE 60.ZEIMER: COMPANY SNAPSHOT
TABLE 61.ZIEMER: PRODUCT PORTFOLIO
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
